EU Backs Novavax Shot as Region’s Fifth COVID-19 Vaccine

The European Union on Monday approved the use of Novavax’s COVID-19 vaccine in people 18 years and older, giving a boost to the U.S. biotech after long delays and paving the way for a fifth shot in the EU as the Omicron variant spreads quickly. Read More